Abstract:Introduction: Non-small cell lung cancer (NSCLC) exhibits heterogeneity with diverse immune cell infiltration patterns that can influence tumor cell behavior and immunotherapy. A comprehensive characterization of the tumor microenvironment can guide precision medicine. Methods: Here, we generated a single-cell atlas of 398170 cells from 52 NSCLC patients, and investigated the imprinted genes and cellular crosstalk for macrophages. Subsequently, we evaluated the effect of tumor cells on macrophages and verified the expression of marker genes using co-culture experiments, flow cytometry and RT-qPCR assays. Results: Remarkable macrophage adaptability to NSCLC environment was observed, which contributed to generating tumor-associated macrophages (TAMs). We identified 5 distinct functional TAM subtypes, of which the majority were SELENOP-positive macrophages, with high levels of SLC40A1 and CCL13 . The TAMs were also involved in mediating CD8 + T cell activity and form intercellular interaction with cancer cells, as indicated by receptor-ligand binding. Indirect coculture of tumor cells SPC-A1 and THP-1 monocytes, produced M2-like TAMs that highly expressed several markers of SELENOP-positive macrophages. The abundance of this type TAMs seemed to be associated with poorer overall survival rates [hazard ratio (HR) = 1.34, 95% confidence interval (CI) = 0.98-1.83, p = 0.068] based on deconvolution of TCGA-LUAD dataset. Discussion: In summary, we provided a high-resolution molecular resource of TAMs, and displayed the acquired properties in the tumor microenvironment. Dynamic crosstalk between TAMs and tumor cells via multiple ligand-receptor pairs were revealed, emphasizing its role in sustaining the pro-tumoral microenvironment and its implications for cancer therapy.

Effect of intercalating drugs on the release of uterine nuclear estrogen receptors.

Crosstalk between Tumor-Associated Macrophages and MicroRNAs: A Key Role in Tumor Microenvironment

Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy.

Tumor-Associated Macrophages: Recent Insights and Therapies

The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy

Crosstalk between cancer and immune cells: Role of tumor‐associated macrophages in the tumor microenvironment

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Macrophage barrier in the tumor microenvironment and potential clinical applications

The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Mechanistic studies of tumor-associated macrophage immunotherapy

Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment

Macrophages as regulators of tumour immunity and immunotherapy

Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives